A federal judge has shut down compounding pharmacies from making cheaper versions of Eli Lilly’s weight loss and diabetes ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

Eli Lilly and Co. Wednesday ... tech mecca in Lebanon, Indiana. Lilly has said the company expects to increase production for its blockbuster weight loss and diabetes drugs at the 9,000 acre ...

FDA-approved medicines," Eli Lilly CEO Dave Ricks said in a statement Wednesday. The company began building out capacity as demand for its blockbuster GLP-1 products — Mounjaro for diabetes and ...

Over the last few years, as Eli Lilly has revealed a series of ... knockoff versions of Lilly’s diabetes and obesity blockbusters Mounjaro and Zepbound. “This bold (investment) reflects ...

Back in December, I argued why I was ready to upgrade the stock of the embattled weight loss drugs leader Eli Lilly and Company (NYSE:LLY) even as it fell into a bear market after peaking in August.

Eli Lilly LLY-2.01%decrease; red down pointing triangle is expanding its offerings of its hit weight-loss drug Zepbound for people who want to pay cash instead of using their health plans ...